SMOC-2 functions as a regulator in multiple pathological and physiological processes:
Ovarian Cancer: SMOC-2 localizes to endothelial cells in ovarian cancer tissues, suggesting a role in tumor angiogenesis .
Hepatocellular Carcinoma (HCC): SMOC-2 promotes HCC cell proliferation by accelerating G1/S cell cycle transition through ERK/p38 MAPK signaling .
Endometrial Carcinoma: Elevated SMOC-2 expression correlates with poor prognosis and advanced tumor stages .
Silencing SMOC-2 reduces kidney fibrosis by inhibiting fibroblast-to-myofibroblast transformation in murine models .
SMOC-2 interacts with extracellular matrix (ECM) components to modulate wound healing and tissue remodeling .
SMOC-2 enhances BMP9-induced osteogenic differentiation in mesenchymal stem cells (MSCs) by upregulating RUNX2 expression .
RNA sequencing revealed SMOC-2 as a downstream target of BMP9 signaling during osteogenesis .
Cross-Reactivity: MAB5140 shows 15% cross-reactivity with human SMOC-1 but none with mouse SMOC-2 .
Storage: Most antibodies require storage at -20°C with avoidance of freeze-thaw cycles .
Validation: Proteintech’s 31063-1-AP validates SMOC-2 in HCT116 cells and mouse brain tissue , while Elabscience’s antibody confirms reactivity in human liver cancer samples .
SMOC-2’s dual role in promoting both tumor progression and tissue repair positions it as a potential therapeutic target. For instance, inhibiting SMOC-2 in cancers like HCC or endometrial carcinoma could suppress metastasis , while enhancing its activity might benefit bone regeneration therapies .
How does SMOC-2 influence cell cycle progression in HCC, and what experimental models best capture this?
How to reconcile contradictory data on SMOC-2’s role in different cancers?
What are optimal protocols for detecting SMOC-2 in low-abundance samples?
Sensitivity Enhancements:
Why do some studies report nuclear SMOC-2 localization while others show cytoplasmic staining?
Resolution:
Epitope specificity determines observed localization. For example:
Recommendation: Include subcellular fractionation assays in experimental design.
| Antibody Clone | Target Region | Cross-Reactivity | Applications |
|---|---|---|---|
| MAB5140 | Gln22-Gly446 | 15% with SMOC-1 | IHC, WB |
| ab198715 | C-terminal | None reported | IHC-P |